Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial

Trials

Volumn 13, Issue , 2012, Pages

  Abner, Erin L ^a   Dennis, Brandon C ^a,b   Mathews, Melissa J ^a,b   Mendiondo, Marta S ^a,b   Caban Holt, Allison ^a,b   Kryscio, Richard J ^a,b   Schmitt, Frederick A ^a,b,d   Crowley, John J ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Clinical trials; Neuropsychological assessment; Practice effects

Indexed keywords

ALPHA TOCOPHEROL; SELENIUM;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY IMPAIRMENT SCREEN; MULTICENTER STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; BIAS (EPIDEMIOLOGY); CANADA; CHI-SQUARE DISTRIBUTION; COGNITION; DRUG THERAPY, COMBINATION; HUMANS; INCIDENCE; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PUERTO RICO; REPRODUCIBILITY OF RESULTS; SELENIUM; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VITAMIN E;

EID: 84869171043     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-217     Document Type: Article

References (37)

1. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological assessment 2004, New York: Oxford University Press, 4th.
2. Meinert CL, McCaffrey LD, Breitner JC. Alzheimer's disease anti-inflammatory prevention trial: design, methods, and baseline results. Alz Dement 2009, 5:93-104.
3. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, . Ginkgo Evaluation of Memory (GEM) Study Investigators Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008, 300:2253-2262. 10.1001/jama.2008.683, 2823569, 19017911, Ginkgo Evaluation of Memory (GEM) Study Investigators.
4. Kryscio RJ, Mendiondo MS, Schmitt FA, Markesbery WR. Designing a large prevention trial: statistical issues. Stat Med 2004, 23:285-296. 10.1002/sim.1716, 14716729.
5. Versavel MvL D, Evertz C, Unger S, Meier F, Kuhlman J. Test-retest reliability and influence of practice effects on performance in a multi-user computerized psychometric test system for use in clinical pharmacological studies. Drug Res 1997, 47:781-786.
6. Benedict RH, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 1998, 20:339-353. 10.1076/jcen.20.3.339.822, 9845161.
7. Bird CM, Kyriaki P, Ricciardelli P, Rossor MN, Cipolotti L. Test-retest reliability, practice effects and reliable change indices for the recognition memory test. British J Clin Psychol 2003, 42:407-425.
8. Cooper DB, Lacritz LH, Weiner MF, Rosenberg RN, Cullum CM. Category fluency in mild cognitive impairment; reduced effect of prectice in test-retest conditions. Alz Dis Assoc Disord 2004, 18:120-122.
9. Falleti MG, Maruff P, Collie A, Darby DG. Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 2006, 28:1095-1112. 10.1080/13803390500205718, 16840238.
10. Troster AI, Woods SP, Morgan EE. Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropyschol 2007, 22:711-718.
11. Folstein MF, Folstein SE, McHugh PR. " Mini-mental state" . A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
12. Galasko D, Abramson I, Corey-Bloom J, Thal LJ. Repeated exposure to the mini-mental state examination and the information memory-concentration test results in a practice effect in Alzheimer's disease. Neurology 1993, 43:1559-1563. 10.1212/WNL.43.8.1559, 8351011.
13. Watson FL, Pasteur ML, Healy DT, Hughes EA. Nine parallel versions of four memory tests: an assessment of form equivalence and the effects of practice on performance. Human Psychopharmacol Clin Exp 1994, 9:51-61.
14. Basso MR, Carona FD, Lowery N, Axelrod BN. Practice effects on the WAIS-III across 3- and 6-month intervals. Clin Neuropsychol 2002, 16:57-63. 10.1076/clin.16.1.57.8329, 11992227.
15. Duff K, Westervelt HJ, McCaffrey RJ, Haase RF. Practice effects, test-retest stability, and dual baseline assessments with the California verbal learning test in an HIV sample. Arch Clin Neuropsychol 2001, 16:461-476.
16. Johnson BF, Hoch K, Johnson J. Variability in psychometric test scores: the importance of the practice effect in patient study design. Prog Neuropsychopharmacol Biol Psychiatry 1991, 15:625-635. 10.1016/0278-5846(91)90052-3, 1956991.
17. McCaffrey RJ, Ortega A, Orsillo SM, Nelles WB. Practice effects in repeated neuropsychological assessments. Clin Neuropsychol 1992, 6:32-42.
18. Mitrushina M, Satz P. Effect of repeated administration of a neuropsychological battery in the elderly. J Clin Psychol 1991, 47:790-801. 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C, 1757583.
19. Rabbitt P, Banerji N, Szymanski A. Space Fortress as an IQ test? Predictions of learning and of practised performance in a complex interactive video-game. Acta Psychol 1989, 71:243-257.
20. Rabbitt P, Diggle P, Holland F, McInnes L. Practice and drop-out effects during a 17-year longitudinal study of cognitive aging. J Gerontol B Psychol Sci Soc Sci 2004, 59:P84-P97. 10.1093/geronb/59.2.P84, 15014091.
21. Rabbitt P, Lunn M, Wong D, Cobain M. Age and ability affect practice gains in longitudinal studies of cognitive change. J Gerontol B Psychol Sci Soc Sci 2008, 63:P235-P240. 10.1093/geronb/63.4.P235, 18689765.
22. Heaton RK, Temkin N, Dikmen S, Avitable N, Taylor MJ, Marcotte TD, Grant I. Detecting change: a comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol 2001, 16:75-91.
23. Dikmen SS, Heaton RK, Grant I, Temkin NR. Test-retest reliability and practice effects of expanded halstead-reitan neuropsychological test battery. J Int Neuropsychol Soc 1999, 5:346-356.
24. McCaffrey RJ, Ortega A, Haase RF. Effects of repeated neuropsychological assessments. Arch Clin Neuropsychol 1993, 8:519-524.
25. Salinsky MC, Storzbach D, Dodrill CB, Binder LM. Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12-16-week period. J Int Neuropsychol Soc 2001, 7:597-605. 10.1017/S1355617701755075, 11459111.
26. Duff K, Beglinger LJ, Schultz SK, Moser DJ, McCaffrey RJ, Haase RF, Westervelt HJ, Langbehn DR, Paulsen JS, . Huntington's Study Group Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index. Arch Clin Neuropsychol 2007, 22:15-24. 1847360, 17142007, Huntington's Study Group.
27. Lippman SM. Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst 2005, 97:94-102. 10.1093/jnci/dji009, 15657339.
28. Kryscio RJ, Abner EL, Schmitt FA, Goodman PJ, Mendiondo M, Caban-Holt A, Dennis BC, Mathews M, Klein EA, Crowley JJ. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: The PREADVISE trial. in press.
29. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, Lipton RB. Screening for dementia with the memory impairment screen. Neurology 1999, 52:231-238. 10.1212/WNL.52.2.231, 9932936.
30. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF. A 5-year longitudinal study of the mini-mental state examination in normal aging. Am J Epidemiol 1997, 145:498-506. 10.1093/oxfordjournals.aje.a009137, 9063339.
31. Duff K, Lyketsos CG, Beglinger LJ, Chelune G, Moser DJ, Arndt S, Schultz SK, Paulsen JS, Petersen RC, McCaffrey RJ. Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatric Psych 2011, 19:932-939.
32. Galvin JE, Powlishta KK, Wilkins K, McKeel DW, Xiong C, Grant E, Storandt M, Morris JC. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol 2005, 62:758-765. 10.1001/archneur.62.5.758, 15883263.
33. Bird CM, Papadopadopoulou K, Ricciardelli P, Rossor MN, Cipolotti L. Test-retest reliability, practice effects and reliable change indices for the recognition memory test. Brit J Clin Psychol 2003, 42:407-425.
34. Chelune GJ, Naugle RI, Luders H, Sedlak J, Awad IA. Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychol 1993, 7:41-52.
35. Sachs BC, Lucas JA, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR, Pedraza O. Reliable change on the Boston naming test. J Int Neuropsychol Soc 2012, 18:375-378. 10.1017/S1355617711001810, 22264406.
36. Pedraza O, Smith GE, Ivnik RJ, Willis FB, Ferman TJ, Petersen RC, Graff-Radford NR, Lucas JA. Reliable change on the dementia rating scale. J Int Neuropsychol Soc 2007, 13:716-720.
37. Ivnik RJ, Smith GE, Lucas JA, Petersen RC, Boeve BF, Kokmen E, Tangalos EG. Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance. Neuropsychol 1999, 13:121-127.